HOME >> BIOLOGY >> NEWS
Protemix corporation announces discovery of way to repair hearts damaged by diabetes

Auckland, New Zealand (August 31, 2004): New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

A study1 published in the September issue of the world-leading journal Diabetes shows that six months treatment with the orally active small molecule, LaszarinTM, brought about a significant reduction towards normal heart size in diabetic patients with cardiac enlargement.

Diabetes is often accompanied by enlargement and dysfunction of the heart and coronary heart disease and these are major causes of death2. According to the World Health Organisation, over 194 million people have diabetes.

The research led by Professor Garth Cooper and Dr. John Baker of Protemix demonstrates for the first time that defective metabolism of copper in people with diabetes is implicated in the development of heart disease. LaszarinTM, developed in New Zealand by Protemix, removes the excess copper from the body.

The study in preclinical models and in Phase 2 human clinical trials in subjects with type-2 diabetes, showed that LaszarinTM caused increased urinary output of copper compared with treated controls. The researchers found reversed heart failure in preclinical models. They also found that the damaged hearts in the preclinical models and humans had substantively regenerated after treatment with LaszarinTM .

Professor Cooper explained: 'The next step is to investigate this novel treatment, which is the first in its class, in Phase 3 trials in humans. We are currently submitting our Investigational New Drug Application (IND) to the US Food and Drug Administration (FDA) to enable this process to occur. If successful in Phase 3, LaszarinTM has a potential worldwide market of over tw
'"/>

Contact: Joan Kureczka
JKureczka@comcast.net
415-821-2413
Kureczka/Martin Associates
30-Aug-2004


Page: 1 2

Related biology news :

1. High CO2 levels hamper nitrate incorporation by plants
2. Nonprofits, corporations can collaborate to improve environmental management
3. Secretary of Energy announces seven E.O. Lawrence Award Winners
4. Popular Science announces Third Annual Brilliant 10
5. The American Phytopathological Society announces 2004 awards
6. NSF announces six FIBR awards to tackle some of biologys most challenging questions
7. JGI announces community sequencing program portfolio
8. APS announces the winners of its 2004 postdoctoral fellowship in physiological genomics
9. National Corn Growers Association announces valuable maize genome data now available to scientists
10. DFG announces three percent budget increase
11. Chemical Society announces EPA awards for environmentally friendly technology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/11/2019)... ... 11, 2019 , ... A new report published by the Family Equality Council ... 77% of those aged 18 to 35 already have or are considering having children, ... and older.(1) Among all LGBTQ prospective parents, 41% are considering assisted reproductive technology (ART) ...
(Date:3/9/2019)... ... March 07, 2019 , ... StressMarq ... stress research tools today announced the publication of its recent PCT patent ... antibody, still at a pre-clinical stage of development, moves the company into the ...
(Date:3/5/2019)... (PRWEB) , ... March 05, 2019 , ... Join this ... how a metadata-driven approach will help data analysts and bioinformaticians focus on data analysis ... unify data that can come from different source systems. Some sources of data include:, ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... ... Konica Minolta, Inc. (Konica Minolta) today announced the formation of their inaugural Scientific ... the advancement of precision medicine that takes into account individual variability in genes, ...
(Date:3/19/2019)... Switzerland (PRWEB) , ... March ... ... at Tel HaShomer, the largest hospital in Israel and the Middle East ... manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will enable Sheba ...
(Date:3/18/2019)... ... 18, 2019 , ... For more than 15 years, USDM Life Sciences ... science companies to easily comply with FDA 21 CFR Part 11 and EMA EudraLex ... service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, including every ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... in Oklahoma City, OK. EyeCRO joins the Department of Veterans Affairs, the Oklahoma ... Center as the fifth institution in Oklahoma to receive this prestigious endorsement. ...
Breaking Biology Technology:
Cached News: